With more than 25 years of experience from its founding companies, Cetero has conducted more than 10,000 clinical pharmacology studies - more than any other CRO. Cetero's proven track record allows the company to provide flexible and high quality drug development services, and its time-tested systems produce consistent and reliable data Cetero's clients can trust.

Cetero's clinical research expertise consists of traditional early-stage, healthy-volunteer clinical pharmacology and bioavailability studies, as well as specialty Phase Ia/b trials in patients. Its bioanalytical services support clinical, preclinical drug and biomarker analysis for small and large molecules. In addition, Cetero owns and operates a full-scale central laboratory supporting Phase I-IV clinical trials in North and South America.

Twenty-five years of experience and knowledge gained from conducting these studies, allows us to provide safety-minded research for Phase I and IIa trials. With a 99 percent on-time rate to start studies on-time, you can trust that your study will begin as scheduled, be enrolled with qualified participants and be completed according to your timelines.

Our North American bioanalytical laboratories have nearly 50 LC/MS/MS, a dedicated team of scientists available to develop, validate or transfer your methods and more than 650 validated assays.

Cetero can also assist with planning, managing and monitoring your Phase II-IV clinical program. Coupled with our in-house clinical and scientific services, rest assured that your late stage drug development needs will be met.

We are committed to providing the service required to ensure your program runs smoothly from preconsultation through final report.

• Clinical Pharmacology
• Expertise in conducting:
• First-in-human
• Interaction studies
• Bioavailability
• Pharmacokinetic (PK)
• Pharmacodynamic (PD)
• Thorough QT
• Proof-of-concept
• Bioanalytical
• Method development, validation and transfer
• More than 650 assays, three laboratories and nearly 50 LC/MS/MS
• Environmental Exposure Chambers
• Seven EECs - controlled studies conducted year-round for:
• Seasonal and perennial allergies
• Asthma
• Non-allergic rhinoconjunctivitis
• Dry eye
• Phase II-IV CRO Services
• Multicenter clinical trial management
• Study design and protocol development through regulatory submission
• Central Lab
• State-of-the-art laboratory for Phase I-IV studies
• Custom-designed profiles, packaging and logistics
• Scientific Affairs
• Drug development and regulatory consultation
• Medical/report writing
• PK/PD
• Biostatistics
• Data management
• Therapeutic Areas
• Allergy
• Asthma
• Dermatology
• Diabetes

Cetero's five clinical pharmacology units have a participant database of more than 100,000 potential healthy and patient volunteers, with more than 30,000 participants dosed each year. Participants accessible through Cetero's database include but are not limited to:

Pharmacology/Toxicology